Published in Thromb J on November 10, 2009
Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography. Semin Thromb Hemost (2010) 1.13
Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery. Surg Endosc (2013) 0.87
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet (1996) 2.75
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Comparison of thrombelastography with common coagulation tests. Thromb Haemost (1981) 1.58
Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit (1987) 1.12
The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost (1995) 1.02
Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations. Anesth Analg (2000) 0.91
Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol (2000) 0.87
Thrombelastography in healthy volunteers, patients with stable angina and acute chest pain. Thromb Res (2000) 0.85
High-dose tinzaparin in pregnancy and the need for urgent delivery. Br J Anaesth (2002) 0.83
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost (1995) 0.83
Thrombelastography monitoring of resistance to enoxaparin anticoagulation in thrombophilic pregnancy patients. Thromb Res (2006) 0.81
Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth (1992) 0.80
Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost (1995) 0.80
Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis. Artif Organs (1990) 0.78
Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine. Am Heart J (2000) 0.78
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost (1995) 0.78
Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors. Am J Cardiol (2013) 2.19
Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. Eur Heart J (2011) 1.54
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm. Biologics (2012) 0.96
[Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger (2003) 0.79
[Resuscitation with automated external defibrillators outside hospital]. Ugeskr Laeger (2005) 0.78
Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost (2009) 0.77
Inadequate use of prophylaxis against venous thromboembolism in Danish medical departments. Dan Med Bull (2011) 0.75
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]. Ugeskr Laeger (2004) 0.75
[Thrombelastography--should it be done and when?]. Ugeskr Laeger (2006) 0.75
[Increased bleeding tendency induced by beta-lactam antibiotics]. Ugeskr Laeger (2005) 0.75
[The use of venous thromboprophylaxis in Danish medical departments. A questionnaire survey]. Ugeskr Laeger (2005) 0.75
[Diagnostic strategy in patients with clinically suspected deep vein thrombosis]. Ugeskr Laeger (2008) 0.75
Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease. J Clin Epidemiol (2012) 0.75